1. Home
  2. SOWG vs ADVB Comparison

SOWG vs ADVB Comparison

Compare SOWG & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sow Good Inc. Common Stock

SOWG

Sow Good Inc. Common Stock

HOLD

Current Price

$0.66

Market Cap

10.1M

ML Signal

HOLD

ADVB

Advanced Biomed Inc. Common Stock

HOLD

Current Price

$0.38

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOWG
ADVB
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
9.7M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
SOWG
ADVB
Price
$0.66
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
140.3K
215.3K
Earning Date
11-14-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,270,357.00
N/A
Revenue This Year
$6.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.34
52 Week High
$4.12
$4.10

Technical Indicators

Market Signals
Indicator
SOWG
ADVB
Relative Strength Index (RSI) 49.63 41.63
Support Level $0.58 $0.37
Resistance Level $0.62 $0.46
Average True Range (ATR) 0.05 0.04
MACD 0.01 -0.00
Stochastic Oscillator 63.94 17.14

Price Performance

Historical Comparison
SOWG
ADVB

About SOWG Sow Good Inc. Common Stock

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: